ZVRA FY 2023 Earnings — Zevra Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ZVRAZevra Therapeutics, Inc.

$618M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$27M+170.3% YoY

Gross Profit

$25M89.3% margin

Operating Income

-$50M-180.6% margin

Net Income

-$46M-167.7% margin

EPS (Diluted)

$-1.30

Cash Flow

Operating Cash Flow

-$34M

Free Cash Flow

-$34M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$172M

Total Liabilities

$110M

Stockholders' Equity

$62M

Cash & Equivalents

$43M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$27M	$10M	+170.3%
Gross Profit	$25M	$10M	+146.7%
Operating Income	-$50M	-$43M	-16.5%
Net Income	-$46M	-$27M	-72.0%